![Heterogeneity of theEGFRmutation status between the primary tumor and metastatic lymph node and the sensitivity toEGFRtyrosine kinase inhibitor in non-small cell lung cancer]()
Heterogeneity of theEGFRmutation status between the primary tumor and metastatic lymph node and the sensitivity toEGFRtyrosine kinase inhibitor in non-small cell lung cancerShimizu, Katsuhiko; Yukawa, Takuro; Hirami, Yuji; Okita, Riki; Saisho, Shinsuke; Maeda, Ai; Yasuda, Koichiro; Nakata, Masao · Targeted Oncology · 2013